CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerDynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer.Expression and Function of CD44 in Epithelial Ovarian CarcinomaMMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer.The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis.Ovarian cancer stem cells: still an elusive entity?Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosisRole of Pericellular Matrix in the Regulation of Cancer Stemness.Spheroid cancer stem cells display reprogrammed metabolism and obtain energy by actively running the tricarboxylic acid (TCA) cycleThe impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer.ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis.Are ovarian cancer stem cells the target for innovative immunotherapy?Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.Changes in mRNA/protein expression and signaling pathways in in vivo passaged mouse ovarian cancer cells.CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor ProgressionPrognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
P2860
Q26773907-B0C03A98-B33E-45D8-834D-761E232459F8Q36108028-C0B5CD1D-1E13-4AFF-A0AF-88F9D122057EQ36409587-7B8E1110-637A-4048-9C64-7900E168A163Q37230791-30AD342F-1B83-461E-B020-0896D8D0170EQ37564029-262E2C12-B950-46E8-B0FF-BDFCC5A40AD2Q37713683-26507312-31B4-46D9-B7D7-2A9E306FDAFAQ38763356-60BBFEA6-053D-40E0-82AC-86DC9F07F3A0Q38770102-40C5BA1F-DD0E-4324-B45C-355EB3BBDB35Q38775029-665F6526-F35C-4D79-8C31-4087457FBB8EQ41279960-A8A60DF1-7D8A-4160-94F8-DDF8CD47AB53Q47138140-126705D1-6030-40A4-8F7C-B77BE24B5E74Q49658859-EC51BE31-D668-4DAC-95B7-5C6C4ED02F8AQ51703765-C83A0FF3-4B6B-4BEB-8DF7-898779FC7836Q55164226-9B8C51E9-8CBD-4815-8820-94DDB006A074Q55309145-DCEFE266-D03A-4658-A5C4-322417B296E5Q55433301-21E693A8-3965-4AC4-B61B-5E0896DE28FBQ58697956-DC082729-C107-45A7-921B-321863685232Q61798737-8e37aeb7-4b2f-a3a7-7c4b-cdfc338d72da
P2860
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CD44 variant 6 is correlated w ...... nced epithelial ovarian cancer
@ast
CD44 variant 6 is correlated w ...... nced epithelial ovarian cancer
@en
type
label
CD44 variant 6 is correlated w ...... nced epithelial ovarian cancer
@ast
CD44 variant 6 is correlated w ...... nced epithelial ovarian cancer
@en
prefLabel
CD44 variant 6 is correlated w ...... nced epithelial ovarian cancer
@ast
CD44 variant 6 is correlated w ...... nced epithelial ovarian cancer
@en
P2093
P2860
P356
P1433
P1476
CD44 variant 6 is correlated w ...... nced epithelial ovarian cancer
@en
P2093
Dashdemberel Narantuya
Francisca Tjhay
Hidetaka Katabuchi
Hironori Tashiro
Isao Sakaguchi
Jianying Guo
Koichi Fujimoto
Ritsuo Honda
Shingo Tayama
Takeshi Motohara
P2860
P304
P356
10.1111/CAS.12765
P577
2015-08-06T00:00:00Z